New cholesterol-lowering combination pill for at-risk adults
Part of Hormones & metabolism clinical trials.
This study tests a new combination pill containing two cholesterol-lowering medications (laroprovstat and rosuvastatin) in people who have never taken cholesterol medicine before. The goal is to see if the combination works better than either medicine alone at lowering LDL cholesterol, which is the 'bad' cholesterol that can increase heart disease risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have not had a heart attack, stroke, or other major heart/blood vessel event
- Your 10-year risk of developing heart disease is estimated as low based on your health profile
- You have not taken any cholesterol-lowering medication in the past 3 months
- You do not have a history of severe allergic reactions or muscle problems from statin drugs (a common cholesterol medicine)
- Your blood pressure and blood sugar (if diabetic) are well controlled with current treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a new medicine, laroprovstat, to a standard cholesterol drug (rosuvastatin) is better at lowering bad cholesterol than the standard drug alone. It might help people who are at high risk for heart disease or stroke.
This trial tests a combination pill of two cholesterol-lowering medicines (pitavastatin and ezetimibe) in adults who have been taking either atorvastatin or rosuvastatin for at least 3 months. It aims to see if switching to this new combination is safe and effective.
This trial compares a lower-dose cholesterol pill (rosuvastatin plus ezetimibe) to a higher-dose version of just rosuvastatin for people with mild to moderate heart artery blockages who have not had a stent or bypass. It aims to see which approach works better and is safer.
This study tests a new oral drug (HS-10510) in healthy people to check its safety and how the body handles it. It may help lower cholesterol, and some parts of the study look at how it works in people with higher cholesterol
This trial tests a new medicine called QLC7401 to lower cholesterol in adults with high cholesterol who are not currently on cholesterol-lowering treatment. It may help reduce the risk of heart problems.
This trial compares two very low LDL-cholesterol targets (below 1.0 vs 1.0-1.39 mmol/L) using extra medications (PCSK9 inhibitors) to see which is safer and better for people at extremely high risk of heart attacks or strokes.
Hear when a new Hypercholesterolaemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.